Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome
To access this article, please choose from the options below
PII: S0010-7824(10)00042-9
doi:10.1016/j.contraception.2010.01.022
© 2010 Elsevier Inc. All rights reserved.
